[
    [
        {
            "time": "",
            "original_text": "医疗健康行业周报 | 康立明生物完成6亿元C轮融资；荣昌生物ADC药物获FDA突破性疗法认定；2019年中国医疗器械进出口总额554.87亿美元",
            "features": {
                "keywords": [
                    "康立明生物",
                    "融资",
                    "荣昌生物",
                    "ADC药物",
                    "FDA",
                    "突破性疗法",
                    "医疗器械",
                    "进出口"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康",
                    "生物医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医疗健康行业周报 | 康立明生物完成6亿元C轮融资；荣昌生物ADC药物获FDA突破性疗法认定；2019年中国医疗器械进出口总额554.87亿美元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药行业一周观察：海外第二波疫情来袭 关注检测板块业绩弹性",
            "features": {
                "keywords": [
                    "医药行业",
                    "海外疫情",
                    "第二波",
                    "检测板块",
                    "业绩弹性"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业一周观察：海外第二波疫情来袭 关注检测板块业绩弹性",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业研究：2020年CSCO大会群星闪耀 24张图表详细梳理亮点荟萃",
            "features": {
                "keywords": [
                    "医药生物",
                    "CSCO大会",
                    "亮点",
                    "研究"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业研究：2020年CSCO大会群星闪耀 24张图表详细梳理亮点荟萃",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]